Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Pavlova S, Malcikova J, Radova L, Bonfiglio S, Cowland JB, Brieghel C, Andersen MK, Karypidou M, Biderman B, Doubek M, Lazarian G, Rapado I, Vynck M, Porret NA, Andres M, Rosenberg D, Sahar D, Martínez-Laperche C, Buño I, Hindley A, Donaldson D, Sánchez JB, García-Marco JA, Serrano-Alcalá A, Ferrer-Lores B, Fernández-Rodriguez C, Bellosillo B, Stilgenbauer S, Tausch E, Nikdin H, Quinn F, Atkinson E, van de Corput L, Yildiz C, Bilbao-Sieyro C, Florido Y, Thiede C, Schuster C, Stoj A, Czekalska S, Chatzidimitriou A, Laidou S, Bidet A, Dussiau C, Nollet F, Piras G, Monne M, Smirnova S, Nikitin E, Sloma I, Claudel A, Largeaud L, Ysebaert L, Valk PJM, Christian A, Walewska R, Oscier D, Sebastião M, da Silva MG, Galieni P, Angelini M, Rossi D, Spina V, Matos S, Martins V, Stokłosa T, Pepek M, Baliakas P, Andreu R, Luna I, Kahre T, Murumets Ü, Pikousova T, Kurucova T, Laird S, Ward D, Alcoceba M, Balanzategui A, Scarfo L, Gandini F, Zapparoli E, Blanco A, Abrisqueta P, Rodríguez-Vicente AE, Benito R, Bravetti C, Davi F, Gameiro P, Martinez-Lopez J, Tazón-Vega B, Baran-Marszak F, Davis Z, Catherwood M, Sudarikov A, Rosenquist R, Niemann CU, Stamatopoulos K, Ghia P, Pospisilova S

Open source

DOI
10.1002/hem3.70065
Published
2025 Jan
Container
HemaSphere
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70065,
  title = {Detection of clinically relevant variants in the TP53 gene below 10\% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.},
  author = {Pavlova S and Malcikova J and Radova L and Bonfiglio S and Cowland JB and Brieghel C and Andersen MK and Karypidou M and Biderman B and Doubek M and Lazarian G and Rapado I and Vynck M and Porret NA and Andres M and Rosenberg D and Sahar D and Martínez-Laperche C and Buño I and Hindley A and Donaldson D and Sánchez JB and García-Marco JA and Serrano-Alcalá A and Ferrer-Lores B and Fernández-Rodriguez C and Bellosillo B and Stilgenbauer S and Tausch E and Nikdin H and Quinn F and Atkinson E and van de Corput L and Yildiz C and Bilbao-Sieyro C and Florido Y and Thiede C and Schuster C and Stoj A and Czekalska S and Chatzidimitriou A and Laidou S and Bidet A and Dussiau C and Nollet F and Piras G and Monne M and Smirnova S and Nikitin E and Sloma I and Claudel A and Largeaud L and Ysebaert L and Valk PJM and Christian A and Walewska R and Oscier D and Sebastião M and da Silva MG and Galieni P and Angelini M and Rossi D and Spina V and Matos S and Martins V and Stokłosa T and Pepek M and Baliakas P and Andreu R and Luna I and Kahre T and Murumets Ü and Pikousova T and Kurucova T and Laird S and Ward D and Alcoceba M and Balanzategui A and Scarfo L and Gandini F and Zapparoli E and Blanco A and Abrisqueta P and Rodríguez-Vicente AE and Benito R and Bravetti C and Davi F and Gameiro P and Martinez-Lopez J and Tazón-Vega B and Baran-Marszak F and Davis Z and Catherwood M and Sudarikov A and Rosenquist R and Niemann CU and Stamatopoulos K and Ghia P and Pospisilova S},
  year = {2025},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70065},
  url = {https://doi.org/10.1002/hem3.70065}
}

RIS

TY  - JOUR
TI  - Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.
AU  - Pavlova S
AU  - Malcikova J
AU  - Radova L
AU  - Bonfiglio S
AU  - Cowland JB
AU  - Brieghel C
AU  - Andersen MK
AU  - Karypidou M
AU  - Biderman B
AU  - Doubek M
AU  - Lazarian G
AU  - Rapado I
AU  - Vynck M
AU  - Porret NA
AU  - Andres M
AU  - Rosenberg D
AU  - Sahar D
AU  - Martínez-Laperche C
AU  - Buño I
AU  - Hindley A
AU  - Donaldson D
AU  - Sánchez JB
AU  - García-Marco JA
AU  - Serrano-Alcalá A
AU  - Ferrer-Lores B
AU  - Fernández-Rodriguez C
AU  - Bellosillo B
AU  - Stilgenbauer S
AU  - Tausch E
AU  - Nikdin H
AU  - Quinn F
AU  - Atkinson E
AU  - van de Corput L
AU  - Yildiz C
AU  - Bilbao-Sieyro C
AU  - Florido Y
AU  - Thiede C
AU  - Schuster C
AU  - Stoj A
AU  - Czekalska S
AU  - Chatzidimitriou A
AU  - Laidou S
AU  - Bidet A
AU  - Dussiau C
AU  - Nollet F
AU  - Piras G
AU  - Monne M
AU  - Smirnova S
AU  - Nikitin E
AU  - Sloma I
AU  - Claudel A
AU  - Largeaud L
AU  - Ysebaert L
AU  - Valk PJM
AU  - Christian A
AU  - Walewska R
AU  - Oscier D
AU  - Sebastião M
AU  - da Silva MG
AU  - Galieni P
AU  - Angelini M
AU  - Rossi D
AU  - Spina V
AU  - Matos S
AU  - Martins V
AU  - Stokłosa T
AU  - Pepek M
AU  - Baliakas P
AU  - Andreu R
AU  - Luna I
AU  - Kahre T
AU  - Murumets Ü
AU  - Pikousova T
AU  - Kurucova T
AU  - Laird S
AU  - Ward D
AU  - Alcoceba M
AU  - Balanzategui A
AU  - Scarfo L
AU  - Gandini F
AU  - Zapparoli E
AU  - Blanco A
AU  - Abrisqueta P
AU  - Rodríguez-Vicente AE
AU  - Benito R
AU  - Bravetti C
AU  - Davi F
AU  - Gameiro P
AU  - Martinez-Lopez J
AU  - Tazón-Vega B
AU  - Baran-Marszak F
AU  - Davis Z
AU  - Catherwood M
AU  - Sudarikov A
AU  - Rosenquist R
AU  - Niemann CU
AU  - Stamatopoulos K
AU  - Ghia P
AU  - Pospisilova S
PY  - 2025
JO  - HemaSphere
DO  - 10.1002/hem3.70065
UR  - https://doi.org/10.1002/hem3.70065
ER  - 

APA

S, P., J, M., L, R., S, B., JB, C., C, B., MK, A., M, K., B, B., M, D., G, L., I, R., M, V., NA, P., M, A., D, R., D, S., C, M., I, B., A, H., D, D., JB, S., JA, G., A, S., B, F., C, F., B, B., S, S., E, T., H, N., F, Q., E, A., L, V. D. C., C, Y., C, B., Y, F., C, T., C, S., A, S., S, C., A, C., S, L., A, B., C, D., F, N., G, P., M, M., S, S., E, N., I, S., A, C., L, L., L, Y., PJM, V., A, C., R, W., D, O., M, S., MG, D. S., P, G., M, A., D, R., V, S., S, M., V, M., T, S., M, P., P, B., R, A., I, L., T, K., Ü, M., T, P., T, K., S, L., D, W., M, A., A, B., L, S., F, G., E, Z., A, B., P, A., AE, R., R, B., C, B., F, D., P, G., J, M., B, T., F, B., Z, D., M, C., A, S., R, R., CU, N., K, S., P, G., & S, P. (2025). Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.. HemaSphere. https://doi.org/10.1002/hem3.70065

Source records